drugset / Trial / NCT00497471

RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

NCT00497471

RandomizedFactorialDouble-blindPrevention

Summary

The purpose of this trial is to evaluate the efficacy of weekly iron supplementation and the efficacy of malaria chemoprophylaxis from 2 to 12 months of age in infants living in an area of intense and perennial malaria transmission

Timeline

Start
1995-02
Primary completion
Completion
1999-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule 25 mg
Subject Iron Sulfate Small molecule 2 mg/kg Oral
Subject pyrimethamine Small molecule 3.125 mg